Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative
$BCLI Q2 '26 Earnings Results & Recap Brainstorm Cell Therapeutics Inc. reported an operating loss of $5,659,000 for the six months ended June 30, 2026, with cash, cash equivalents, and restricted cash totaling $209,000 at period end.

Price since post

Full Details

Advertisement|Remove ads.